Immune thrombocytopenia (ITP): vizsgálatok itt: Svájc
1 of 1 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Real-world Study of Treatment Patterns and Outcomes in Primary Immune Thrombocytopenia Patients Treated With Eltrombopag
- Where
- Basel
- Életkor
- 18 év to 100 év
- People
- 150
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07587723